Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
PaperCitations, authors & open-access status
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 128 citations, 2017 year and hybrid oa status.
128
Citations
2017
Year
hybrid
OA Status